Top 5 Medical Apps on Android in Turkey: Q4 2022 Performance

During the fourth quarter of 2022, the top five medical apps on the Android platform in Turkey exhibited diverse performance metrics in terms of downloads, revenue, and active users. Here’s a closer look at how these apps fared:

Anatomy 3D Atlas from Catfish Animation Studio showed a consistent weekly revenue trend, peaking at approximately $109 in the first week of December. The app's weekly downloads saw a significant decline from 1.5K in late October to just 277 by the end of December. Similarly, weekly active users dropped from 2.3K at the start of the quarter to around 1.3K by the end.

Anatomy Learning - 3D Anatomy published by 3D Medical OU, experienced a peak in weekly downloads in mid-October, reaching 6.5K. However, downloads decreased sharply to 561 by the final week of December. The app's weekly revenue also demonstrated fluctuations, peaking at $125 in mid-November. Active users peaked at 9.5K in mid-October, before declining to approximately 4.1K by the end of the quarter.

Complete Anatomy 2024 by 3D4Medical from Elsevier maintained steady weekly revenue, peaking at $125 in the final weeks of December. Weekly downloads remained relatively low, with a slight increase from 96 in early December to 178 by the end of the month. Active users showed a small rise towards the end of December, reaching 602.

Sanford Guide from Antimicrobial Therapy, Inc. had stable revenue throughout the quarter, peaking at $133 in mid-December. Weekly downloads were minimal, with occasional small spikes. Active users remained relatively steady, averaging around 40 users throughout most of the quarter.

Human Anatomy Atlas 2025 by Visible Body saw a notable peak in weekly revenue at $92 in late November. However, weekly downloads were minimal, with the highest being 155 in late November.

These insights, derived from Sensor Tower data, highlight the varied performance of these top medical apps in Turkey during Q4 2022. For more detailed insights, visit Sensor Tower.